Health
Companies scramble to expand coronavirus vaccine supply – The Washington Post
Pfizer and Moderna have been working to increase production and reporting success, but supply will fall short of global demand. Other vaccine companies are lagging…
I think the U.S. will most probably be one of the first countries of size to get its population protected, Stéphane Bancel, chief executive of Moderna, said this week at a keynote panel for the JP Morgan Healthcare Conference, an annual biopharmaceutical investor conference.
But doses on paper are different from vials in the freezer or vaccinations in peoples arms, as the past months have demonstrated. Distribution challenges have received most of the attention, as unused doses stack up. But the…
Continue Reading
